GSK and Oxford researchers to create cancer vaccine to stop disease developing
GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.
PharmiWeb17h
GSK and Oxford establish the GSK-Oxford Cancer Immuno-Prevention Programme to advance novel cancer research
GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...
emjreviews.com11h
GSK and Oxford unite to advance cancer vaccine research
The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.
pharmaphorum5d
GSK’s Neale Belson on building trust with employees and society
Building this trust among employees involves ... is aiming to “do the right thing” for wider society. With the new goals, GSK aims to have a net zero impact on climate and a net positive ...